Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Introduction: Physician burnout is a common problem across the field of medicine, resulting in significant negative personal and work-related consequences. We set out to explore the prevalence of burnout in cardiac electrophysiologists (EPs).
Methods: A national registry of EPs (N = 112) was sent a two-item questionnaire, established and validated to assess the experience of Burnout. In total, 51 EPs completed the questionnaire from 2020 to 2023.
Results: 36% of the sampled cardiac electrophysiologists reported burnout, and 26% reported feelings of callousness.
Conclusion: This significant number of EPs experiencing symptoms of burnout underscores the critical need for enhanced focus on the EP workforce.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12063195 | PMC |
| http://dx.doi.org/10.1111/pace.15187 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Cardiac Implantable Electronic Devices and Transcatheter Tricuspid Valve Replacement With the EVOQUE System: A Case-Review Series Highlighting Procedural and Management Considerations.
Struct Heart
September 2025
The Carl and Edyth Lindner Research Center at the Christ Hospital, Cincinnati, Ohio, USA.
Severe, untreated tricuspid regurgitation is associated with worse clinical outcomes. While isolated tricuspid valve (TV) surgery has been linked to poor long-term outcomes, transcatheter TV therapies, including edge-to-edge repair and transcatheter tricuspid valve replacement (TTVR), have emerged as effective alternatives and have been shown to improve outcomes, leading to their regulatory approval in the United States. Conduction system abnormalities are commonly seen among patients undergoing TTVR due to the close proximity of the atrioventricular node and the His bundle to the TV annulus.
View Article and Find Full Text PDFNational Tunisian Multicenter Prospective Study on Cardiac Implantable Electronic Devices (Tunisian NATURE-CIED study): One-year complications and predictive factors.
Heart Rhythm O2
August 2025
Cardiology Department, Pasteur Clinic, Tunis, Tunisia.
Background: The prevalence of cardiac implantable electronic devices (CIEDs) in Tunisia is rising because of increased life expectancy and broader indications. This has led to a higher incidence of complications related to vascular access, device pockets, leads, and patient characteristics.
Objective: We aimed to evaluate the prevalence, types, and predictors of complications occurring within the first year after CIED implantation and to profile the demographic and epidemiologic characteristics of CIED recipients in Tunisia.
Improving outcomes of atrial fibrillation ablation by integrated personalized lifestyle interventions: a randomized controlled trial.
Eur Heart J
August 2025
Department of Cardiology, Catharina Hospital Eindhoven, the Netherlands.
Background And Aims: Atrial fibrillation (AF) is associated with various lifestyle risk factors. Their presence negatively affects AF catheter ablation outcomes. This study evaluates the efficacy of a nurse-led, integrated lifestyle programme on ablation outcomes.
View Article and Find Full Text PDFRole of Artificial Intelligence in Reducing Data Deluge From Cardiac Implantable Electronic Devices.
JACC Adv
August 2025
Kansas City Heart Rhythm Institute, HCA Midwest Health, Overland Park, Kansas, USA. Electronic address:
Background: Remote monitoring (RM) is the standard of care for patients with cardiac implantable electronic devices (CIEDs). Data deluge from RM of CIEDs is one of the major challenges being faced by cardiac device clinics.
Objectives: The purpose of this study was to highlight the role of artificial intelligence (AI) in reducing data deluge from CIEDs and to elucidate its performance in augmenting the traditional device clinic workforce.
Optimizing the Diagnosis and Management of Nocturnal Hypertension: An Expert Consensus from India.
J Assoc Physicians India
July 2025
Associate Vice President, Medical Services, Alembic Pharmaceuticals Ltd., Mumbai, Maharashtra, India, Corresponding Author.
Nocturnal hypertension, characterized by high blood pressure (BP) during nighttime, is a critical but often overlooked contributor to heart disease and organ damage. Globally, nocturnal hypertension is estimated to affect 6-20% of the population. Data indicating the prevalence of nocturnal hypertension in India is not available.
View Article and Find Full Text PDF